HIV infection is one of the health problems plaguing resource-poor countries. There are limited data on the prevalence in remote towns and districts. In this study, we aimed at investigating the seroprevalence of HIV in Moyamba District using data from voluntary counseling and testing(VCT), prevention of mother-to-child transmission of HIV(PMCT) and from blood donors from 2013 to 2016.
BACKGROUD
In Sierra Leone, the first reports of HIV were in 1987 (NAS/MOHS 2002) . The country then had about 11 years of civil war from 1991 to 2002. The war was characterized by massive displacement of people, rape, high level of prostitution that seemed to accelerate the HIV prevalence (Human Rights Watch 2003) .
Serious countrywide interventions against HIV commenced in the year 2002, when Sierra Leone had the first national HIV seroprevalence (NAS/MOHS 2002) and also established the prevention of motherto-child transmission (PMCT) policy that required all pregnant women to be tested for HIV (http://www.nas.gov.sl/interventions/pmtct, accessed, 9/12/16) . Voluntary counseling and testing(VCT) and screening of blood products for HIV had been instituted earlier.
However, about 49% of women and 82% of men are yet to be tested for HIV (NAS/MOHS 2015) . The low level of HIV testing has been associated with stigma and lack of appropriate understanding about HIV (Bhoobun et al., 2014 , Kelly, Weiser, & Tsai, 2016 .
Population-based surveys were carried out in 2008 and 2013 reporting the national HIV prevalence to be stabilized and at 1.5% seroprevalence (Statistics Sierra Leone and ICF International 2014). And the epidemic currently affects over 50,000 persons including about 2166 new infections and there are about 23,000 orphans due to the HIV problem in Sierra Leone (WHO 2016).
In Moyamba, the site of this study, apart from the DHS reports, there is a paucity of data on HIV epidemic. A peek into the HIV situation in Moyamba district was observed during the Ebola outbreak, when several suspected EVD patients were diagnosed with HIV and posed challenges in EVD treatment (Arranz et al, 2016) .
Screening for HIV using established programmes such as the VCT, PMCT and blood donor screening are important for determining the HIV situation in a remote population such as Moyamba.
The goal of this study was to determine the seroprevalence of HIV in Moyamba from healthy blood donors, VCT and PMCT cases from 2013 to October 2016.
Methods
The study was carried out in the Moyamba District which is one of four districts in Southern Sierra Leone and has a land area of The study was carried out in the Moyamba District which is one of four districts in Southern Sierra Leone and has a land area of 6902km 2 . The land is divided into 14 chiefdoms which asre further divided into 143 sections, and a total of 1617 communities (DOtW and MdM 2015 For the period covered by the study, 2013 to 2016, 16,745 women were tested by PMCT in Moyamba and 153(0.91%) were positive for HIV (Table 2 ). There was a significant difference between prevalence in 2015 and 2014(P=0.001) and also between the rates in 2015 and 2013(P=00.1). The prevalence among blood donors, who are healthy volunteers seemed to match with the 1.5% stabilized epidemic described earlier (NAS/MOHS 2015) .
VCT prevalence was expected to be higher than the PMCT and blood donor HIV prevalence. Many VCT clients normally opt for an HIV tests after potential exposures to the virus.
Our study had several limitations. First, we used data collected and entered into hospital records, we did not generate the data primarily and could not ascertain whether the test kits were stored at the right temperature as described by their inserts or if the tests were done within the specified time indicated in the user inserts. We do however know that the tests were performed by trained and qualified technicians who could have performed according to the guidelines by the Sierra Leone Ministry of Health and Sanitation.
Additionally, we were unable to use age metadata because the data did not have age for all datasets.
Conclusions
Our result provides an update on the HIV situation in Moyamba and shows an epidemic that is consistent with the national seroprevalence of 1.5%. Our findings from PMCT, VCT and blood donors relate with recent international calls for HIV surveillance (Supervie and Costagliola 2016; UNAIDS 2014; van Sighem et al. 2015) .
Further research on HIV using a randomized study design with healthy volunteers in a longitudinal cohort could help to determine the incidence of the disease in Moyamba.
